PT84818B - Processo para a preparacao de derivados de di-hidro-oxazol, di-hidro-tiazol e di-hidro-imidazol - Google Patents
Processo para a preparacao de derivados de di-hidro-oxazol, di-hidro-tiazol e di-hidro-imidazolInfo
- Publication number
- PT84818B PT84818B PT84818A PT8481887A PT84818B PT 84818 B PT84818 B PT 84818B PT 84818 A PT84818 A PT 84818A PT 8481887 A PT8481887 A PT 8481887A PT 84818 B PT84818 B PT 84818B
- Authority
- PT
- Portugal
- Prior art keywords
- dihydro
- thiazol
- oxazole
- hydro
- preparing
- Prior art date
Links
- ZABMHLDQFJHDSC-UHFFFAOYSA-N 2,3-dihydro-1,3-oxazole Chemical compound C1NC=CO1 ZABMHLDQFJHDSC-UHFFFAOYSA-N 0.000 title 1
- LWTIGYSPAXKMDG-UHFFFAOYSA-N 2,3-dihydro-1h-imidazole Chemical class C1NC=CN1 LWTIGYSPAXKMDG-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868610909A GB8610909D0 (en) | 1986-05-03 | 1986-05-03 | Compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT84818A PT84818A (en) | 1987-06-01 |
| PT84818B true PT84818B (pt) | 1989-12-29 |
Family
ID=10597340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT84818A PT84818B (pt) | 1986-05-03 | 1987-05-04 | Processo para a preparacao de derivados de di-hidro-oxazol, di-hidro-tiazol e di-hidro-imidazol |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4861789A (pt) |
| EP (1) | EP0251453B1 (pt) |
| JP (1) | JPS62267270A (pt) |
| AU (1) | AU600939B2 (pt) |
| DE (1) | DE3767789D1 (pt) |
| DK (1) | DK227487A (pt) |
| ES (1) | ES2031890T3 (pt) |
| GB (1) | GB8610909D0 (pt) |
| GR (1) | GR3001416T3 (pt) |
| NZ (1) | NZ220179A (pt) |
| PT (1) | PT84818B (pt) |
| ZA (1) | ZA873169B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034406A (en) * | 1989-09-26 | 1991-07-23 | Allergan, Inc. | Method for reducing or maintaining intraocular pressure |
| US5066664A (en) * | 1990-02-28 | 1991-11-19 | Allergan, Inc. | 2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents |
| DK148292D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Forbindelser |
| US5580892A (en) * | 1993-10-22 | 1996-12-03 | Allergan | Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents |
| US6150389A (en) | 1994-07-11 | 2000-11-21 | Allergan Sales, Inc. | Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents |
| EP0770068B1 (en) * | 1994-07-11 | 2001-11-28 | Allergan Sales, Inc. | Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents |
| DE19514579A1 (de) | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
| US5677321A (en) * | 1996-02-29 | 1997-10-14 | Synaptic Pharmaceutical Corporation | 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands |
| WO2007093292A2 (en) * | 2006-02-15 | 2007-08-23 | Bayer Cropscience Ag | Insecticidal substituted amino heterocyclic and heteroaryl derivatives |
| EP1988080A1 (en) * | 2007-05-03 | 2008-11-05 | Bayer CropScience AG | Insecticidal substituted 2-aminoindanes |
| WO2008145615A2 (en) * | 2007-05-25 | 2008-12-04 | Basf Se | Aminoazoline and urea derivatives for combating animal pests |
| KR101642520B1 (ko) * | 2007-08-15 | 2016-07-25 | 알러간, 인코포레이티드 | 아드레날린성 화합물 |
| KR20100071990A (ko) * | 2007-08-15 | 2010-06-29 | 알러간, 인코포레이티드 | 녹내장 및 통증과 같은 질환의 처치에 유용한 헤테로사이클 치환된 융합 카르보사이클 |
| JP2010536780A (ja) * | 2007-08-15 | 2010-12-02 | アラーガン インコーポレイテッド | 治療化合物 |
| BRPI0906925A2 (pt) * | 2008-01-18 | 2019-09-24 | Allergan Inc | agentes adrenérgicos do subtipo alfa 2 seletivos e métodos de uso dos mesmos |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2870159A (en) * | 1957-07-08 | 1959-01-20 | Pfizer & Co C | Hydrogenated 2-(1-naphthylamino)-oxazolines |
| US2883410A (en) * | 1957-07-08 | 1959-04-21 | Pfizer & Co C | N-(1-indanyl)-n'-(beta-substituted ethyl)-ureas |
| US2870161A (en) * | 1957-07-08 | 1959-01-20 | Pfizer & Co C | 2-(1-indanyl amino)-oxazolines |
| DE1195323B (de) * | 1963-06-24 | 1965-06-24 | Thomae Gmbh Dr K | Verfahren zur Herstellung von 2-[5', 6', 7', 8'-Tetrahydronaphthyl-(1')-amino]-imidazolin und seinen Salzen |
| US3432600A (en) * | 1963-09-30 | 1969-03-11 | Du Pont | Partially reduced 2-(1-napthylamino) oxazoline,indanylethylureas,and indanylaminooxazoline |
| US3679798A (en) * | 1964-02-28 | 1972-07-25 | Du Pont | Composition comprising arylaminooxazoline and antichloligeneric agent |
| DE1670751A1 (de) * | 1966-09-27 | 1970-12-23 | Bayer Ag | Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen |
| DE1670753A1 (de) * | 1966-09-27 | 1970-07-16 | Bayer Ag | Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen |
| US3882229A (en) * | 1972-07-21 | 1975-05-06 | Nordmark Werke Gmbh | Composition and method for shrinking mucous membranes |
| JPS54151990A (en) * | 1978-04-17 | 1979-11-29 | Beiersdorf Ag | Novel condensated nitrogenncontained heterocyclic compound and its manufacture |
-
1986
- 1986-05-03 GB GB868610909A patent/GB8610909D0/en active Pending
-
1987
- 1987-05-04 PT PT84818A patent/PT84818B/pt not_active IP Right Cessation
- 1987-05-04 US US07/047,720 patent/US4861789A/en not_active Expired - Fee Related
- 1987-05-04 NZ NZ220179A patent/NZ220179A/xx unknown
- 1987-05-04 AU AU72479/87A patent/AU600939B2/en not_active Ceased
- 1987-05-04 ZA ZA873169A patent/ZA873169B/xx unknown
- 1987-05-04 DK DK227487A patent/DK227487A/da not_active Application Discontinuation
- 1987-05-05 DE DE8787304019T patent/DE3767789D1/de not_active Expired - Fee Related
- 1987-05-05 ES ES198787304019T patent/ES2031890T3/es not_active Expired - Lifetime
- 1987-05-05 EP EP87304019A patent/EP0251453B1/en not_active Expired - Lifetime
- 1987-05-06 JP JP62110422A patent/JPS62267270A/ja active Pending
-
1991
- 1991-01-31 GR GR91400101T patent/GR3001416T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3001416T3 (en) | 1992-09-25 |
| DE3767789D1 (de) | 1991-03-07 |
| DK227487A (da) | 1987-11-04 |
| AU600939B2 (en) | 1990-08-30 |
| NZ220179A (en) | 1989-10-27 |
| ZA873169B (en) | 1988-04-27 |
| JPS62267270A (ja) | 1987-11-19 |
| ES2031890T3 (es) | 1993-01-01 |
| AU7247987A (en) | 1987-11-05 |
| US4861789A (en) | 1989-08-29 |
| PT84818A (en) | 1987-06-01 |
| GB8610909D0 (en) | 1986-06-11 |
| EP0251453B1 (en) | 1991-01-30 |
| DK227487D0 (da) | 1987-05-04 |
| EP0251453A2 (en) | 1988-01-07 |
| EP0251453A3 (en) | 1988-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT82890B (pt) | Processo para a preparacao de novos derivados de n-aralquil-piperidinametanol | |
| FI873180A7 (fi) | Uudet hetratsepiinit ja menetelmä niiden valmistamiseksi. | |
| PT84273B (pt) | Processo para a preparacao de derivados da dicloroanilina | |
| BR8907517A (pt) | Processo para a preparacao de amonia | |
| KR880003938A (ko) | 에리트로마이신 a 유도체 및 그의 제조 방법 | |
| PT88224A (pt) | Processo para a preparacao de derivados fenil-tiadiazinona, oxadiazinona e triazinona | |
| PT89780A (pt) | Processo para a preparacao de derivados da tetrahidroisoquinolina | |
| PT84561B (pt) | Processo aperfeicoado para a preparacao de derivados macrolidos | |
| PT96411A (pt) | Processo para a preparacao de derivados de azaoxindole | |
| PT84124B (pt) | Processo para a preparacao duma composicao estavel de nicorandilo | |
| ES552525A0 (es) | Un metodo para preparar derivados de cefem | |
| FI863776A7 (fi) | Menetelmä 7-aminomitosaanijohdannaisten valmistamiseksi. | |
| PT82445B (pt) | Processo para a preparacao de novos derivados glicopeptidicos | |
| PT88180A (pt) | Processo para a preparacao de derivados alquilaminoalcoxifenilo | |
| PT89927A (pt) | Processo para a preparacao de agentes citotoxicos especificados para celulas | |
| BR8706915A (pt) | Processo para a preparacao de derivados metoxibenzofenona,metoxibenzofenonas e composto | |
| PT84587B (pt) | Processo para preparacao de uma enzima fibrinolitica | |
| PT96322A (pt) | Processo para a preparacao de derivados de glicerol | |
| PT91205A (pt) | Processo para a preparacao de 2-aminopurina | |
| PT84459B (pt) | Processo para a preparacao de derivados de ciclopropano 1,1-dissubstituidos | |
| BR8701512A (pt) | Processo para a preparacao de betume | |
| PT85608A (pt) | Processo para a preparacao de derivados de fenil-etanolamina | |
| PT83531B (pt) | Processo para a preparacao de derivados de dicloroanilina | |
| PT84590B (pt) | Processo para a preparacao de uma enzima fibrinolitica | |
| BR8702314A (pt) | Processo para producao de ureia ciclica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19911226 |